Search
Browse
Statistics
Feeds

Metabolite ratios as potential biomarkers for type 2 diabetes: a DIRECT study

[thumbnail of 16774oa.pdf]
Preview
PDF - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
562kB

Item Type:Article
Title:Metabolite ratios as potential biomarkers for type 2 diabetes: a DIRECT study
Creators: Molnos, S., Wahl, S., Haid, M., Eekhoff, E.M.W., Pool, R., Floegel, A., Deelen, J., Much, D., Prehn, C., Breier, M., Draisma, H.H., van Leeuwen, N., Simonis-Bik, A.M.C., Jonsson, A., Willemsen, G., Bernigau, W., Wang-Sattler, R., Suhre, K., Peters, A., Thorand, B., Herder, C., Rathmann, W., Roden, M., Gieger, C., Kramer, M.H.H., van Heemst, D., Pedersen, H.K., Gudmundsdottir, V., Schulze, M.B., Pischon, T. ORCID logoORCID: https://orcid.org/0000-0003-1568-767X, de Geus, E.J.C., Boeing, H., Boomsma, D.I., Ziegler, A.G., Slagboom, P.E., Hummel, S., Beekman, M., Grallert, H., Brunak, S., McCarthy, M.I., Gupta, R., Pearson, E.R., Adamski, J. and 't Hart, L.M.
Abstract:AIMS/HYPOTHESIS: Circulating metabolites have been shown to reflect metabolic changes during the development of type 2 diabetes. In this study we examined the association of metabolite levels and pairwise metabolite ratios with insulin responses after glucose, glucagon-like peptide-1 (GLP-1) and arginine stimulation. We then investigated if the identified metabolite ratios were associated with measures of OGTT-derived beta cell function and with prevalent and incident type 2 diabetes. METHODS: We measured the levels of 188 metabolites in plasma samples from 130 healthy members of twin families (from the Netherlands Twin Register) at five time points during a modified 3 h hyperglycaemic clamp with glucose, GLP-1 and arginine stimulation. We validated our results in cohorts with OGTT data (n = 340) and epidemiological case-control studies of prevalent (n = 4925) and incident (n = 4277) diabetes. The data were analysed using regression models with adjustment for potential confounders. RESULTS: There were dynamic changes in metabolite levels in response to the different secretagogues. Furthermore, several fasting pairwise metabolite ratios were associated with one or multiple clamp-derived measures of insulin secretion (all p < 9.2 x 10-7). These associations were significantly stronger compared with the individual metabolite components. One of the ratios, valine to phosphatidylcholine acyl-alkyl C32:2 (PC ae C32:2), in addition showed a directionally consistent positive association with OGTT-derived measures of insulin secretion and resistance (p </= 5.4 x 10-3) and prevalent type 2 diabetes (ORVal_PC ae C32:2 2.64 [beta 0.97 +/- 0.09], p = 1.0 x 10-27). Furthermore, Val_PC ae C32:2 predicted incident diabetes independent of established risk factors in two epidemiological cohort studies (HRVal_PC ae C32:2 1.57 [beta 0.45 +/- 0.06]; p = 1.3 x 10-15), leading to modest improvements in the receiver operating characteristics when added to a model containing a set of established risk factors in both cohorts (increases from 0.780 to 0.801 and from 0.862 to 0.865 respectively, when added to the model containing traditional risk factors + glucose). CONCLUSIONS/INTERPRETATION: In this study we have shown that the Val_PC ae C32:2 metabolite ratio is associated with an increased risk of type 2 diabetes and measures of insulin secretion and resistance. The observed effects were stronger than that of the individual metabolites and independent of known risk factors.
Keywords:Epidemiology, Insulin Secretion, Metabolomics, Prediction of Diabetes, Type 2 Diabetes
Source:Diabetologia
ISSN:0012-186X
Publisher:Springer
Volume:61
Number:1
Page Range:117-129
Date:January 2018
Official Publication:https://doi.org/10.1007/s00125-017-4436-7
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library